A bitter pill
The Japanese courts recently vetoed a drug company's efforts to stop generic rivals from selling their products in lookalike packaging. John Tessensohn and Shusaku Yamamoto explain what the trade dress decision means for the pharmaceutical industry in one of the world's most lucrative drugs markets
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
